XML 27 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
 
 
 
(in thousands)
 
Royalty Rights - At Fair Value
Beginning Balance at December 31, 2013
 

 
 
 
 
 
 
Transfer into Level 3
 
235,677

 
Total change in fair value for the period
 
 
 
 
Included in earnings
 
(4,061
)
 
Purchases, issues, sales, and settlements
 
 
 
 
Purchases
 
15,500

 
 
 
 
 
Ending Balance at June 30, 2014
 
$
247,116

Schedule of fair value of financial instruments measured on recurring basis
 
 
June 30, 2014
 
December 31, 2013
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
 
$
155,107

 
$

 
$

 
$
155,107

 
$
85,970

 
$

 
$

 
$
85,970

Corporate securities
 

 
3,243

 

 
3,243

 

 
5,238

 

 
5,238

Royalty rights - at fair value
 

 

 
247,116

 
247,116

 

 

 
235,677

 
235,677

Total
 
$
155,107

 
$
3,243

 
$
247,116

 
$
405,466

 
$
85,970

 
$
5,238

 
$
235,677

 
$
326,885

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial liabilities:
 
 

 
 

 
 
 
 

 
 

 
 

 
 
 
 

Foreign currency hedge contracts
 
$

 
$
4,199

 
$

 
$
4,199

 
$

 
$
8,871

 
$

 
$
8,871

Schedule of fair value of assets and liabilities not subject to fair value recognition by level within the valuation hierarchy

 
 
June 30, 2014
 
December 31, 2013
 
 
Carrying Value
 
Fair Value
Level 2
 
Fair Value
Level 3
 
Carrying Value
 
Fair Value
Level 2
 
Fair Value
Level 3
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Wellstat Diagnostics note receivable
 
$
50,191

 
$

 
$
50,191

 
$
47,694

 
$

 
$
46,042

Hyperion
 
1,200

 

 
1,200

 
1,194

 

 
1,195

AxoGen note receivable and embedded derivative
 
28,942

 

 
27,160

 
26,544

 

 
25,785

Avinger note receivable
 
20,422

 

 
19,336

 
20,250

 

 
19,061

LENSAR note receivable
 
39,591

 

 
40,842

 
39,572

 

 
39,572

Durata note receivable
 
40,000

 

 
39,402

 
24,995

 

 
24,995

Direct Flow Medical note receivable
 
35,049

 

 
34,723

 
34,799

 

 
34,799

Paradigm Spine note receivable
 
49,517

 

 
51,165

 

 

 

kaléo note receivable
 
155,407

 

 
155,407

 

 

 

Total
 
$
420,319

 
$

 
$
419,426

 
$
195,048

 
$

 
$
191,449

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 

 
 

 
 

 
 

 
 

 
 

Series 2012 Notes
 
$
47,160

 
$
88,523

 
$

 
$
172,630

 
$
277,650

 
$

May 2015 Notes
 
150,797

 
248,889

 

 
148,253

 
212,304

 

February 2018 Notes
 
272,824

 
341,955

 

 

 

 

Term loan
 
37,364

 
37,500

 

 
74,397

 
75,000

 

Total
 
$
508,145

 
$
716,867

 
$

 
$
395,280

 
$
564,954

 
$